Expression of CD23 in the germinal center of thymus from myasthenia gravis patients

Hiroyuki Murai, Hideo Hara, Tomoko Hatae, Takuro Kobayashi, Takeshi Watanabe

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

In order to investigate a pathogenic role of germinal centers which appear in the hyperplastic thymus of myasthenia gravis (MG) patients, we performed an immunohistochemical study using various monoclonal antibodies including CD23. In contrast with tonsilar germinal centers from non-MG individuals. CD23 was strongly and diffusely expressed in the whole area of germinal centers of MG thymi, including the outer zone. In addition, we measured the serum level of soluble CD23 (sCD23) in MG patients at various clinical stages. The high serum sCD23 levels, which were noted in the unthymectomized patients, fell to within normal range over 5 years after thymectomy, and the decline of serum sCD23 correlated well with clinical improvement. CD23 is thought to be responsible for preventing unselected germinal center B cells from entering apoptosis and, in turn, leads to the survival of auto-reactive B cell clones.

Original languageEnglish
Pages (from-to)61-69
Number of pages9
JournalJournal of Neuroimmunology
Volume76
Issue number1-2
DOIs
Publication statusPublished - Jun 1 1997

Fingerprint

Germinal Center
Myasthenia Gravis
Thymus Gland
B-Lymphocytes
Serum
Thymectomy
Reference Values
Clone Cells
Monoclonal Antibodies
Apoptosis

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Cite this

Expression of CD23 in the germinal center of thymus from myasthenia gravis patients. / Murai, Hiroyuki; Hara, Hideo; Hatae, Tomoko; Kobayashi, Takuro; Watanabe, Takeshi.

In: Journal of Neuroimmunology, Vol. 76, No. 1-2, 01.06.1997, p. 61-69.

Research output: Contribution to journalArticle

Murai, Hiroyuki ; Hara, Hideo ; Hatae, Tomoko ; Kobayashi, Takuro ; Watanabe, Takeshi. / Expression of CD23 in the germinal center of thymus from myasthenia gravis patients. In: Journal of Neuroimmunology. 1997 ; Vol. 76, No. 1-2. pp. 61-69.
@article{78dcbafb6cdd4fc9a2177e3f09796232,
title = "Expression of CD23 in the germinal center of thymus from myasthenia gravis patients",
abstract = "In order to investigate a pathogenic role of germinal centers which appear in the hyperplastic thymus of myasthenia gravis (MG) patients, we performed an immunohistochemical study using various monoclonal antibodies including CD23. In contrast with tonsilar germinal centers from non-MG individuals. CD23 was strongly and diffusely expressed in the whole area of germinal centers of MG thymi, including the outer zone. In addition, we measured the serum level of soluble CD23 (sCD23) in MG patients at various clinical stages. The high serum sCD23 levels, which were noted in the unthymectomized patients, fell to within normal range over 5 years after thymectomy, and the decline of serum sCD23 correlated well with clinical improvement. CD23 is thought to be responsible for preventing unselected germinal center B cells from entering apoptosis and, in turn, leads to the survival of auto-reactive B cell clones.",
author = "Hiroyuki Murai and Hideo Hara and Tomoko Hatae and Takuro Kobayashi and Takeshi Watanabe",
year = "1997",
month = "6",
day = "1",
doi = "10.1016/S0165-5728(97)00030-1",
language = "English",
volume = "76",
pages = "61--69",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Expression of CD23 in the germinal center of thymus from myasthenia gravis patients

AU - Murai, Hiroyuki

AU - Hara, Hideo

AU - Hatae, Tomoko

AU - Kobayashi, Takuro

AU - Watanabe, Takeshi

PY - 1997/6/1

Y1 - 1997/6/1

N2 - In order to investigate a pathogenic role of germinal centers which appear in the hyperplastic thymus of myasthenia gravis (MG) patients, we performed an immunohistochemical study using various monoclonal antibodies including CD23. In contrast with tonsilar germinal centers from non-MG individuals. CD23 was strongly and diffusely expressed in the whole area of germinal centers of MG thymi, including the outer zone. In addition, we measured the serum level of soluble CD23 (sCD23) in MG patients at various clinical stages. The high serum sCD23 levels, which were noted in the unthymectomized patients, fell to within normal range over 5 years after thymectomy, and the decline of serum sCD23 correlated well with clinical improvement. CD23 is thought to be responsible for preventing unselected germinal center B cells from entering apoptosis and, in turn, leads to the survival of auto-reactive B cell clones.

AB - In order to investigate a pathogenic role of germinal centers which appear in the hyperplastic thymus of myasthenia gravis (MG) patients, we performed an immunohistochemical study using various monoclonal antibodies including CD23. In contrast with tonsilar germinal centers from non-MG individuals. CD23 was strongly and diffusely expressed in the whole area of germinal centers of MG thymi, including the outer zone. In addition, we measured the serum level of soluble CD23 (sCD23) in MG patients at various clinical stages. The high serum sCD23 levels, which were noted in the unthymectomized patients, fell to within normal range over 5 years after thymectomy, and the decline of serum sCD23 correlated well with clinical improvement. CD23 is thought to be responsible for preventing unselected germinal center B cells from entering apoptosis and, in turn, leads to the survival of auto-reactive B cell clones.

UR - http://www.scopus.com/inward/record.url?scp=0030904235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030904235&partnerID=8YFLogxK

U2 - 10.1016/S0165-5728(97)00030-1

DO - 10.1016/S0165-5728(97)00030-1

M3 - Article

C2 - 9184633

AN - SCOPUS:0030904235

VL - 76

SP - 61

EP - 69

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -